Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...

Medication-related cognitive impairment is common, mimics neurodegenerative disease, increases with polypharmacy, and may be prevented with regular cognitive assessment monitoring.

A study has found a new biomarker of schizophrenia, which could also serve as a drug target for treating cognitive symptoms such as disorganised thinking or executive function. Schizophrenia is a ...

Overall, 68.5% of patients reported cognitive symptoms. Cancer patients frequently experience cognitive symptoms, and these symptoms are especially common among patients with brain or central nervous ...

Occupational physical activity was linked to cognitive decline, whereas voluntary leisure exercise provided mental health ...

No individual antipsychotic was associated with better cognitive outcomes than placebo in patients with schizophrenia spectrum disorders (SSD), according to a systematic review and network ...

AI is transforming how we think and work—but at a cognitive cost. This piece explores “AI brain fry,” the pressures driving ...

Survey data showed that a third of Parkinson's patients reported a cognitive symptom soon after diagnosis. Most common were problems with memory, language or word finding, and concentration or ...

Having multiple menopause symptoms may increase a person’s risk of cognitive decline, a new study finds. Image credits: Hakan & Sophie/Stocksy. Menopause, the end of a woman’s reproductive years, ...